Biotech Patenting

Venue: Crowne Plaza Hotel

Location: London, United Kingdom

Event Date/Time: Sep 25, 2006 End Date/Time: Sep 26, 2006
Report as Spam


Maximising protection and value of your company’s biotechnology has become increasingly complex as patent law continually evolves to keep pace with the rapid developments in biotechnology innovation. But in this big money, high stakes area, it is vital for survival to have an up-to-the-minute in-depth understanding of the very latest decisions of the European and US courts and Patent Office policies and practice.

Do you know how the impact and scope of the landmark “Bolar” provision in Europe will affect you? Have you changed your drafting methods in light of recent case law? Can you overcome the challenges faced when patenting antibodies and nanobiotech inventions? Are you up-to-date on avoiding sufficiency of disclosure objections?

Hear from the representatives from the EPO, top industry experts and their advisers. They will provide you with practical tips and comprehensive information from their own experiences on:

• How to deal with enablement, written description and sufficiency objections
• How to claim broad nanobiotech inventions
• Proactive measures for effective enforcement in China
• The impact of the new Bolar provision in the EU
• How to successfully prosecute and enforce patents in India and China
• The most important case law on enforcement
• Brand new methods of claim construction
• How to conduct your due diligence and identify the risks
• Effective claiming for antibodies
• Crucial update on SPCs in the EU and US